TY - JOUR KW - Animals KW - Humans KW - leprosy KW - Mice KW - Pakistan KW - Recurrence KW - Risk Factors KW - Sensitivity and Specificity KW - Time Factors KW - World Health Organization AU - Linder K AU - Zia M AU - Kern WV AU - Pfau RK M AU - Wagner D AB -

OBJECTIVES: To compare a new scoring system for multibacillary (MB) leprosy relapses, which combines time factor, risk factors and clinical presentation at relapse, to WHO criteria.

METHODS: Data were collected on all relapses diagnosed between 1998 and 2004 at the Marie-Adelaide-Centre in Karachi, Pakistan, including case histories, clinical manifestations, follow-up, bacterial indices, treatment and contacts. For the diagnosis of MB relapses a simple scoring system was developed and validated on a data-set of mouse foot pads (MFP)-confirmed relapses (Leprosy Reviews, 76, 2005, 241). Its sensitivity was further evaluated in the Karachi relapse cohort. The P-value was calculated with McNemar's test with continuity correction.

RESULTS: The new scoring system that combines time factor, risk factors and clinical presentation at relapse had a higher sensitivity in MFP-confirmed relapses than the WHO-criteria (95%vs. 65%, P < 0.01). The sensitivity of the scoring system was also significantly higher than the WHO criteria in the 57 cases of MB-relapses diagnosed in Karachi (72%vs. 54%, P < 0.05).

CONCLUSIONS: This new simple scoring system for diagnosing MB-relapses in leprosy should be further validated in a prospective study to confirm its superior sensitivity and to evaluate the specificity of these criteria by using MFP-confirmation for patients presenting with signs of activity after treatment.

BT - Tropical medicine & international health : TM & IH C1 - http://www.ncbi.nlm.nih.gov/pubmed/18397393?dopt=Abstract DA - 2008 Mar DO - 10.1111/j.1365-3156.2008.02003.x IS - 3 J2 - Trop. Med. Int. Health LA - eng N2 -

OBJECTIVES: To compare a new scoring system for multibacillary (MB) leprosy relapses, which combines time factor, risk factors and clinical presentation at relapse, to WHO criteria.

METHODS: Data were collected on all relapses diagnosed between 1998 and 2004 at the Marie-Adelaide-Centre in Karachi, Pakistan, including case histories, clinical manifestations, follow-up, bacterial indices, treatment and contacts. For the diagnosis of MB relapses a simple scoring system was developed and validated on a data-set of mouse foot pads (MFP)-confirmed relapses (Leprosy Reviews, 76, 2005, 241). Its sensitivity was further evaluated in the Karachi relapse cohort. The P-value was calculated with McNemar's test with continuity correction.

RESULTS: The new scoring system that combines time factor, risk factors and clinical presentation at relapse had a higher sensitivity in MFP-confirmed relapses than the WHO-criteria (95%vs. 65%, P < 0.01). The sensitivity of the scoring system was also significantly higher than the WHO criteria in the 57 cases of MB-relapses diagnosed in Karachi (72%vs. 54%, P < 0.05).

CONCLUSIONS: This new simple scoring system for diagnosing MB-relapses in leprosy should be further validated in a prospective study to confirm its superior sensitivity and to evaluate the specificity of these criteria by using MFP-confirmation for patients presenting with signs of activity after treatment.

PY - 2008 SP - 295 EP - 309 T2 - Tropical medicine & international health : TM & IH TI - Relapses vs. reactions in multibacillary leprosy: proposal of new relapse criteria. UR - http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2008.02003.x/pdf VL - 13 SN - 1365-3156 ER -